BHCM
VTVT icon

Brevan Howard Capital Management’s vTv Therapeutics VTVT Stock Holding History

Brevan Howard Capital Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Buy
+7,531
New +$273K ﹤0.01% 1623

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Brevan Howard Capital Management's VTVT Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in vTv Therapeutics (VTVT) in Q1 2026: 7,531 shares worth $299K. The stake represents ﹤0.01% of the portfolio and ranks #1623 among its holdings.

35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Brevan Howard Capital Management held 7,531 shares of vTv Therapeutics worth $299K as of Q1 2026.
  • vTv Therapeutics was a new Brevan Howard Capital Management position in Q1 2026.
  • vTv Therapeutics made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1623 holding.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.